Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- C-RESULTSIndependent statistical analysis of Correcting Residual Errors With Spectral, Ultrasound, Traditional Speech Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03737318).
- C-RESULTSIndependent statistical analysis of Delineation of Sensorimotor Subtypes Underlying Residual Speech Errors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03736213).
- C-ScanIndependent statistical analysis of Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- C-SmartManageIndependent statistical analysis of Web-Based Cognitive Behavioral Stress Management for Latino Sexual Minority Men Living With HIV and Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- C. Difficile and Ursodiol: Complete Statistical AnalysisIndependent statistical analysis of C. Difficile and Ursodiol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02748616).
- C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks: Complete Statistical AnalysisIndependent statistical analysis of C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- C1INHDGFIndependent statistical analysis of C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- C3Independent statistical analysis of Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- C3POIndependent statistical analysis of Cerebral Perfusion Pressure Using Precedex and Other Sedatives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01169467).
- C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain: Complete Statistical AnalysisIndependent statistical analysis of C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CAIndependent statistical analysis of Effectiveness Study of Different Local Anesthetic Mixtures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01243112).
- Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cabozantinib for Adults With Advanced Soft Tissue Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib for Adults With Advanced Soft Tissue Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755195).
- Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01466036).
- Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC): Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631744).
- Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CACD1Independent statistical analysis of Cardiovascular Risk Stratification in Young People With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05283538).
- CADIndependent statistical analysis of Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- cAd3-Marburg Vaccine in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of cAd3-Marburg Vaccine in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03475056).
- CADDIEIndependent statistical analysis of CADDIE Trial - Computer Aided Diagnosis and Detection for Intelligent Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CADENCEIndependent statistical analysis of A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CADENCE-MISIndependent statistical analysis of EDWARDS INTUITY Valve System CADENCE-MIS Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02672553).
- CADETTEIndependent statistical analysis of Cardiac Displacement From Third Trimester to Early Childhood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02583763).
- CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL): Complete Statistical AnalysisIndependent statistical analysis of CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CAESARIndependent statistical analysis of Candesartan Effect in Second Stage Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00621153).
- CAFIndependent statistical analysis of Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CAFETERIAIndependent statistical analysis of Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Caffeine to Reduce Mechanical Ventilation in Preterm Infants: Complete Statistical AnalysisIndependent statistical analysis of Caffeine to Reduce Mechanical Ventilation in Preterm Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01751724).
- CAFIIndependent statistical analysis of Coil Assisted Flow Diversion Safety and Performance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04187573).
- Calcium Absorption in Patients With Rothmund-Thomson Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Calcium Absorption in Patients With Rothmund-Thomson Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01304407).
- Calf Deep Vein Thrombosis Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of Calf Deep Vein Thrombosis Treatment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03590743).
- Cali Sin Tos Aim 2: Complete Statistical AnalysisIndependent statistical analysis of Cali Sin Tos Aim 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06338462).
- CALIPSOIndependent statistical analysis of CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CALMIndependent statistical analysis of Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CALMextIndependent statistical analysis of CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext): primary endpoint results, effect estimate with confidence interval, sample-size…
- CamelliaIndependent statistical analysis of Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CAMELLIA-TIMIIndependent statistical analysis of A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus…
- Caminamos: A Smartphone App to Connect With Walking Partners: Complete Statistical AnalysisIndependent statistical analysis of Caminamos: A Smartphone App to Connect With Walking Partners: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03059901).
- Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT): Complete Statistical AnalysisIndependent statistical analysis of Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04583592).
- CAMP-1Independent statistical analysis of Cantharidin Application in Molluscum Patients-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03377790).
- CAMP-2Independent statistical analysis of Cantharidin Application in Molluscum Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03377803).
- CAMPBELIndependent statistical analysis of CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing’s Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor: Complete Statistical AnalysisIndependent statistical analysis of CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?: Complete Statistical AnalysisIndependent statistical analysis of Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Can Addition of Doxycycline Perioperatively Reduce Propionibacterium Acnes in Shoulder Arthroplasty?: Complete Statistical AnalysisIndependent statistical analysis of Can Addition of Doxycycline Perioperatively Reduce Propionibacterium Acnes in Shoulder Arthroplasty?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?: Complete Statistical AnalysisIndependent statistical analysis of Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CAN QuitIndependent statistical analysis of Connecting Alaska Native People to Quit Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03645941).